Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabien Dépis
Observed names:
Depis, Fabien,
Fabien Depis
Institution:
GentiBio (United States)
Observed institutions:
University of Geneva,
Brigham and Women's Hospital,
Harvard University,
Merrimack Pharmaceuticals (United States),
Light Chain Bioscience (Switzerland),
Jounce Therapeutics (United States),
GentiBio (United States)
show all 7
OpenAlex ID:
A5087846470
T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow
2017
·
Arielle Glatman Zaretsky
, Christoph Konradt
, et al.
·
Cell Reports
·
121
PDF
Antibody-mediated targeting of TNFR2 activates CD8 + T cells in mice and promotes antitumor immunity
2019
·
Eric M. Tam
, Ross B. Fulton
, et al.
·
Science Translational Medicine
·
67
PDF
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody
2022
·
Jessica D. Weaver
, Edward C. Stack
, et al.
·
OncoImmunology
·
65
Pivotal Involvement of Fcγ Receptor IIA in the Neutralization of Lipopolysaccharide Signaling via a Potent Novel Anti-TLR4 Monoclonal Antibody 15C1
2007
·
Irene Dunn-Siegrist
, Olivier Leger
, et al.
·
Journal of Biological Chemistry
·
55
PDF
Selective Antibody Intervention of Toll-like Receptor 4 Activation through Fc γ Receptor Tethering
2014
·
Limin Shang
, Bruno Daubeuf
, et al.
·
Journal of Biological Chemistry
·
39
PDF
Unstable FoxP3 + T regulatory cells in NZW mice
2016
·
Fabien Dépis
, Ho-Keun Kwon
, et al.
·
Proceedings of the National Academy of Sciences
·
27
Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases
2012
·
Yann Dean
, Fabien Dépis
, et al.
·
Swiss Medical Weekly
·
27
PDF
Long‐term amelioration of established collagen‐induced arthritis achieved with short‐term therapy combining anti‐CD3 and anti–tumor necrosis factor treatments
2012
·
Fabien Dépis
, Eric Hatterer
, et al.
·
Arthritis & Rheumatism
·
14
Characterization of a surrogate murine antibody to model anti-human CD3 therapies
2013
·
Fabien Dépis
, Eric Hatterer
, et al.
·
mAbs
·
11
PDF
Abstract 4532: Preclinical evaluation of JTX-1811, an anti-CCR8 antibody with enhanced ADCC activity, for preferential depletion of tumor-infiltrating regulatory T cells
2020
·
Fabien Dépis
, Changyun Hu
, et al.
·
Cancer Research
·
8
Long term amelioration of established collagen-induced arthritis achieved with short term therapy combining anti-CD3 and anti-TNF treatments
2012
·
Depis, Fabien
·
Archive ouverte UNIGE (University of Geneva)
·
3
Editorial: Advancing Treg cell therapy: a comprehensive review series
2026
·
Fabien Depis
, Devan Moodley
, et al.
·
Frontiers in Immunology
PDF
Stable Expression of FOXP3 and Core Tolerogenic Genes by Engineered Human Tregs
2023
·
Payam Zarin
, Martina Sassone-Corsi
, et al.
·
The Journal of Immunology
PDF
Show more works
View as search
Works count:
13
Citation count:
437
H-index:
9
I10-index:
9
Year
Topic
Type